Company Information

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE264.80-0.55 (-0.21 %)
PREV CLOSE ( ) 265.35
OPEN PRICE ( ) 267.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35287
TODAY'S LOW / HIGH ( )262.75 271.75
52 WK LOW / HIGH ( )258.6 328.6
NSE265.05-1.1 (-0.41 %)
PREV CLOSE( ) 266.15
OPEN PRICE ( ) 269.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 265.05 (177)
VOLUME 260008
TODAY'S LOW / HIGH( ) 262.40 272.10
52 WK LOW / HIGH ( )250.1 329
ChairmanJai Hiremath
Managing DirectorSameer Hiremath
Company SecretaryRajasekhar Reddy
Non Executive DirectorBaba Kalyani
Amit Kalyani
Promoter & Non-Executive DirectorSugandha Hiremath
Non Executive Independent DirectorPrakash Mehta
Kannan Unni
Shivani Bhasin Sachdeva
Shrikrishna K Adivarekar
Berjis M Desai
V Ramachandra Kaundinya
Incorporation Year : 1988

Registered Office :

Address : 717 / 718,Maker Chambers V,Nariman Point Mumbai,
Maharashtra-400021 .

Phone : 022-39267100 / 62770477

Email :  info@hikal.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.